Heron Patrick J Insider Trades

Insider Trading History

Track insider trading activity for Heron Patrick J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $456k 3,772 shares
Last Trade
Jun 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$581k 5,752 shares
$101.00
$120.89
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $864k 32,213 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477k 22,445 shares
$21.23
$26.81
MBX Biosciences Common Stock
MBX Biosciences Common Stock MBX
10% owner
Holding Value $707k 12,500 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 12,500 shares
$30.91
$56.59
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $39.6M 327,585 shares
Last Trade
Jan 23, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$15M 159,277 shares
$94.29
$120.89
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $55.5M 459,010 shares
Last Trade
Jan 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.4M 131,425 shares
$94.29
$120.89
MBX Biosciences Common Stock
MBX Biosciences Common Stock MBX
10% owner
Holding Value $295M 5,219,440 shares
Last Trade
Sep 26, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12M 666,666 shares
$18.00
$56.59
HilleVax
HilleVax HLVX
Director
Holding Value $35.9k 17,199 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.3k 17,199 shares
$1.88
$2.09
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $736k 27,448 shares
Last Trade
Jun 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$34.6k 2,646 shares
$13.08
$26.81
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
10% owner
Holding Value $709k 26,435 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$278k 20,568 shares
$13.50
$26.81
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $665k 24,802 shares
Last Trade
Jun 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.07k 378 shares
$13.41
$26.81
MBX Biosciences Common Stock
MBX Biosciences Common Stock MBX
10% owner
Holding Value $905k 16,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$190k 16,000 shares
$11.86
$56.59
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $655k 24,424 shares
Last Trade
Jun 04, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.2k 1,890 shares
$13.32
$26.81
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $758k 6,268 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$276k 6,268 shares
$44.00
$120.89
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $0 0 shares
Last Trade
May 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$251k 5,703 shares
$44.00
$120.89
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $689k 5,703 shares
Last Trade
May 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$251k 5,703 shares
$44.00
$120.89
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $604k 22,534 shares
Last Trade
May 22, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$34.4k 2,520 shares
$13.65
$26.81
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $537k 20,014 shares
Last Trade
May 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$34.4k 2,520 shares
$13.66
$26.81
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $469k 17,494 shares
Last Trade
May 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$34.3k 2,520 shares
$13.62
$26.81
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $401k 14,974 shares
Last Trade
May 14, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$86.7k 6,300 shares
$13.76
$26.81
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $233k 8,674 shares
Last Trade
May 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$32.7k 2,374 shares
$13.76
$26.81

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up